Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1461557

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1461557

Global Transplantation Market Size, Share, Growth Analysis, By Application(Organ Transplantation, and Tissue Transplantation), By End-Use(Hospitals, Transplant Centers) - Industry Forecast 2024-2031

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

Global Transplantation Market size was valued at USD 15 Billion in 2022 and is poised to grow from USD 16.4 Billion in 2023 to USD 33.39 Billion by 2031, at a CAGR of 9.3% during the forecast period (2024-2031).

The transplantation market plays a crucial role in offering patients suffering from organ failure a viable option to restore organ function and enhance their quality of life. Its growth is fueled by the escalating prevalence of chronic diseases globally, driven by factors like aging populations and lifestyle changes. Conditions such as kidney disease, liver disease, and heart failure contribute significantly to the increasing demand for transplantation procedures. Moreover, advancements in surgical techniques, immunosuppressive medications, and tissue engineering technologies have notably improved transplant success rates, further stimulating market expansion. However, the sector faces challenges due to the intricate nature of transplant procedures, necessitating specialized infrastructure, skilled healthcare professionals, and comprehensive post-transplant care. The high costs associated with transplantation, including pre-transplant evaluations, surgeries, follow-up care, and immunosuppressive medications, create financial strains on healthcare systems and patients, affecting access to transplantation services. Nevertheless, the transplantation market presents promising opportunities for growth, with technological innovations such as machine perfusion for organ preservation and the development of novel immunosuppressive drugs offering potential to enhance transplant outcomes. Additionally, initiatives aimed at increasing awareness about organ donation and transplantation, along with governmental support and collaborations among healthcare entities, hold promise in addressing the organ shortage and expanding transplantation programs. Sustained efforts in research, infrastructure enhancement, and public education are essential to meet the escalating demand and improve access to transplantation services globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transplantation Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transplantation Market Segmental Analysis

The global transplantation market is segmented on the basis of application, end-use, and region. By application, the market is segmented into organ transplantation, and tissue Transplantation. By End-Use, the market is segmented into hospitals, transplant centers, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Transplantation Market

The increasing prevalence of chronic illnesses like end-stage renal disease, liver cirrhosis, heart failure, and respiratory disorders has driven the need for organ transplantation. This is evidenced by the surge in demand for procedures such as kidney and pancreas transplants, spurred by the expanding diabetic population and its associated complications.

Restraints in the Global Transplantation Market

The process of organ transplantation encompasses substantial expenses, spanning from pre-transplant assessments to surgery, post-operative recuperation, and the ongoing necessity of immunosuppressive drugs. These financial demands place strains on patients, healthcare systems, and insurance companies alike. Moreover, the inadequate coverage and reimbursement schemes for transplant-related procedures exacerbate the challenges surrounding the affordability and availability of transplantation services.

Market Trends of the Global Transplantation Market

Precision medicine strategies seek to customize transplant treatments by taking into account unique genetic profiles, immunological compatibility, and specific disease attributes. This approach involves employing biomarkers, genetic assessments, and sophisticated diagnostic tools to individualize immunosuppressive treatments, thereby enhancing patient results.

Product Code: SQMIG35D2158

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges

Key Market Insights

  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Regulatory Landscape
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
    • Political Impact
    • Economic Impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Global Transplantation Market by Application

  • Market Overview
  • Organ Transplantation
  • and Tissue Transplantation

Global Transplantation Market by End-Use

  • Market Overview
  • Hospitals
  • Transplant Centers
  • and Others

Global Transplantation Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
    • By Development
    • By Company
    • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021

Key Company Profiles

  • Medtronic (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Novartis AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AbbVie Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zimmer Biomet Holdings, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CSL Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Johnson & Johnson (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Holding AG (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanofi (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck & Co., Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Astellas Pharma Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bristol-Myers Squibb Company (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takeda Pharmaceutical Company Limited (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AstraZeneca (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Medical Care AG & Co. KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences Holdings Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Organogenesis Holdings Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Terumo Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!